North America Intradermal Injections Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Method (Normal Sized Needles, Short Needle, and Without Needle), Application (Tuberculin Skin Test, Allergy Test, Local Aesthetics, and Others), End Us

North America Intradermal Injections Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Method (Normal Sized Needles, Short Needle, and Without Needle), Application (Tuberculin Skin Test, Allergy Test, Local Aesthetics, and Others), End User (Hospitals, Diagnostic Laboratories, Academics and Research Institutes, and Others)

The North America intradermal injections market is expected to reach US$ 2,859.3 million by 2028 from US$ 1,342.5 million in 2021; it is estimated to grow at a CAGR of 11.4% from 2021 to 2028. The increasing cases of cancer, tuberculosis, and allergies drive the growth of the market. As per the data of WHO, about 10 million cases of tuberculosis are observed every year and all of them are diagnosed using tuberculin skin test involving the use of intradermal injection. Along with this, several studies concluded that the intradermal injection could improve the uptake of various cancers and immunological drugs while it can also be used to deliver the gene therapies. Further, continuously increasing cases of COVID-19 would offer lucrative opportunities for the market as various intradermal preparations are under investigation and about to get approved in future. As population in North America is increasing continuously, the number of cases would also increase in near future, which is expected to increase the demand for intradermal injections in the coming years. Further, the novel intradermal injection devices such as Tropis ID of Pharmajet shows prominent results in delivering various drugs for targeting a wide range of diseases and expands the therapeutic area of the intradermal products.

Based on method, the intradermal injections market is segmented into normal-sized needles, short needles, and without needles. In 2020, the normal-sized needles segment accounted for the largest share. However, the short needles segment is expected to register the highest CAGR during the forecast period.

Due to COVID-19 outbreak, many cities were closed. Therefore, doctors/surgeons canceled or postponed the treatment meetings. The patients suffering from critical surgeries, such as neurosurgery, spinal surgery, and ENT surgery, require physical awareness and need to implement procedures in the clinics. The infection of novel coronavirus also results in the reduction of immunity in the recovered patients. Hence, incidence of several other infections such as tuberculosis and skin allergies increased exponentially among the population. Therefore, the demand for various medical devices including intradermal injection also increased, which boosted the growth of the intradermal injection market. As per the data of WHO, there is a reduction of 21% in the number of tuberculosis treatment receiving population at North America during the COVID-19 pandemic and it leads to increase in the death rate of tuberculosis. Besides the complete lockdown in 2020, the number of aesthetic procedures increased remarkably, which also propelled the growth of the market. Since the COVID-19 outbreak reached a pandemic status, the entire North America supply chain was affected, commencing logistic capabilities and production capacity disruption. Therefore, COVID-19 pandemic had a substantial negative impact on the intradermal injection market.

The overall North America intradermal injections market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. The process also serves the purpose of obtaining an overview and forecast for the North America intradermal injections market with respect to all the segments pertaining to the region. Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data, as well as to gain more analytical insights into the topic. Participants of this process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers, along with external consultants such as valuation experts, research analysts, and key opinion leaders, specializing in the North America intradermal injections market. Companies adopt a few strategies, such as mergers and acquisitions and market initiatives, which promotes market growth. BD; West Pharmaceutical Services, Inc.; Terumo Corporation; NanoPass; Pharmajet; Idevax; EUNSUNG GLOBAL; Crossject; Cardinal Health Inc.; and Hindustan Syringes and Medical Devices Ltd are among the major players operating in the market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America intradermal injections market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the North America intradermal injections market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.